E. Karampli - Academia.edu (original) (raw)
Uploads
Papers by E. Karampli
Over the recent decades, advances in healthcare technology have led to significant improvements i... more Over the recent decades, advances in healthcare technology have led to significant improvements in the quality of healthcare and in population health. At the same time, technological change in healthcare, rising national income and expansion of insurance coverage have been acknowledged as the main determinants of the historical growth in health spending in industrialized countries. The pharmaceutical sector is of particular interest as it constitutes a market characterized by rapid technological change and high expenditure growth rates. The purpose of this article is to provide an overview of research findings on the impact of pharmaceutical innovation on pharmaceutical expenditure growth, total health expenditure and population health outcomes and to bring forward the challenges that arise for pharmaceutical policy in Greece.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē
Atrial fibrillation (AF) is the most frequent cardiac arrhythmia in the general population. AF ma... more Atrial fibrillation (AF) is the most frequent cardiac arrhythmia in the general population. AF management patterns have important implications for both the patient's quality of life and the utilisation of healthcare resources. This study aimed to investigate the management pattern of AF among cardiologists in the Greek healthcare setting. In order to construct the outpatient management model, the patient record data of 149 geographically distributed physicians were used. Data on inpatient resource utilisation were obtained from a consensus panel of AF experts. 89.6% of AF patients were treated with pharmacological agents, whereas 5.2% of patients were treated with invasive methods and 5.2% received no treatment. In 59.5% of patients under pharmacological therapy, a rhythm-control strategy was implemented, whereas for the remaining 40.5% of patients a rate-control strategy was selected. Class Ic and III antiarrhythmic agents constituted the main therapeutic choices in the rhythm-...
Over the recent decades, advances in healthcare technology have led to significant improvements i... more Over the recent decades, advances in healthcare technology have led to significant improvements in the quality of healthcare and in population health. At the same time, technological change in healthcare, rising national income and expansion of insurance coverage have been acknowledged as the main determinants of the historical growth in health spending in industrialized countries. The pharmaceutical sector is of particular interest as it constitutes a market characterized by rapid technological change and high expenditure growth rates. The purpose of this article is to provide an overview of research findings on the impact of pharmaceutical innovation on pharmaceutical expenditure growth, total health expenditure and population health outcomes and to bring forward the challenges that arise for pharmaceutical policy in Greece.
Hellenic journal of cardiology : HJC = Hellēnikē kardiologikē epitheōrēsē
Atrial fibrillation (AF) is the most frequent cardiac arrhythmia in the general population. AF ma... more Atrial fibrillation (AF) is the most frequent cardiac arrhythmia in the general population. AF management patterns have important implications for both the patient's quality of life and the utilisation of healthcare resources. This study aimed to investigate the management pattern of AF among cardiologists in the Greek healthcare setting. In order to construct the outpatient management model, the patient record data of 149 geographically distributed physicians were used. Data on inpatient resource utilisation were obtained from a consensus panel of AF experts. 89.6% of AF patients were treated with pharmacological agents, whereas 5.2% of patients were treated with invasive methods and 5.2% received no treatment. In 59.5% of patients under pharmacological therapy, a rhythm-control strategy was implemented, whereas for the remaining 40.5% of patients a rate-control strategy was selected. Class Ic and III antiarrhythmic agents constituted the main therapeutic choices in the rhythm-...